| Title | Authors (identified) | Published In | Identifier(s) | Topic | Published Date |
|---|
| Developing Treatment Guidelines During a Pandemic Health Crisis: Lessons Learned From COVID-19 | [1]Safia Kuriakose, [2]Kanal Singh, [3]Alice K. Pau, [4]Eric S Daar, [5]Rajesh Gandhi, [6]Pablo Tebas, [7]Laura Evans, [8]Roy M Gulick, [9]H. Clifford Lane, [10]Henry Masur [Full author list] | Annals of Internal Medicine [curation] | DOI: 10.7326/M21-1647
| COVID-19 pandemic [curation]; COVID-19 [curation] | 2021-08-01 |
| A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus | [1]Hyeree Choi, [2]Sagar B Kudchodkar, [3]Michelle Ho, [4]Emma L Reuschel, [5]Erin Reynolds, [6]Ziyang Xu, [7]Devivasha Bordoloi, [8]Kenneth E Ugen, [9]Pablo Tebas, [10]Joseph Kim, [11]Mohamed Abdel-Mohsen, [12]Saravanan Thangamani, [13]David B. Weiner, [14]Karuppiah Muthumani [Full author list] | PLoS Neglected Tropical Diseases [curation] | DOI: 10.1371/JOURNAL.PNTD.0008788
PubMed: 33119599 | Powassan virus [curation] | 2020-10-29 |
| NK Response Correlates with HIV Decrease in Pegylated IFN-α2a-Treated Antiretroviral Therapy-Suppressed Subjects | [1]Emmanouil Papasavvas, [2]Livio Azzoni, [3]Andrew V Kossenkov, [4]Noor Dawany, [5]Knashawn H Morales, [6]Matthew Fair, [7]Brian N Ross, [8]Kenneth Lynn, [9]Agnieszka Mackiewicz, [10]Karam Mounzer, [11]Pablo Tebas, [12]Jeffrey M Jacobson, [13]Jay R Kostman, [14]Louise Showe, [15]Luis J Montaner [Full author list] | Journal of Immunology [curation] | DOI: 10.4049/JIMMUNOL.1801511
PubMed: 31253727 | | 2019-06-28 |
| CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells | [1]Mohamed Abdel-Mohsen, [2]Leticia Kuri-Cervantes, [3]Judith Grau-Exposito, [4]Adam M Spivak, [5]Racheal A Nell, [6]Costin Tomescu, [7]Surya Kumari Vadrevu, [8]Leila B Giron, [9]Carla Serra-Peinado, [10]Meritxell Genescà Ferrer, ..., [27]Douglas Richman, [28]Bonnie Howell, [29]Pablo Tebas, [30]Javier Martinez-Picado, [31]Vicente Planelles, ... [Full author list] | Science Translational Medicine [curation] | DOI: 10.1126/SCITRANSLMED.AAR6759
PubMed: 29669853 | HIV [curation] | 2018-04-01 |
| Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study | [1]John H. Beigel, [2]Pablo Tebas, [3]Marie-Carmelle Elie-Turenne, [4]Ednan Bajwa, [5]Todd E Bell, [6]Charles B Cairns, [7]Shmuel Shoham, [8]Jaime G Deville, [9]Eric Feucht, [10]Judith Feinberg, ... [Full author list] | The Lancet. Respiratory medicine [curation] | DOI: 10.1016/S2213-2600(17)30174-1
PubMed: 28522352 | multicenter clinical trial [curation] | 2017-05-15 |
| Urine assay for tenofovir to monitor adherence in real time to tenofovir disoproxil fumarate/emtricitabine as pre-exposure prophylaxis | [1]Helen Koenig, [2]K Mounzer, [3]G W Daughtridge, [4]C E Sloan, [5]L Lalley-Chareczko, [6]G S Moorthy, [7]S C Conyngham, [8]A F Zuppa, [9]L J Montaner, [10]Pablo Tebas [Full author list] | HIV Medicine [curation] | DOI: 10.1111/HIV.12518
PubMed: 28444867 | tenofovir [curation]; emtricitabine [curation] | 2017-04-26 |
| Current use of statins reduces risk of HIV rebound on suppressive HAART | [1]Henning Drechsler, [2]Colby R Ayers, [3]James Cutrell, [4]Naim M. Maalouf, [5]Pablo Tebas, [6]Roger Bedimo [Full author list] | PLOS One [curation] | DOI: 10.1371/JOURNAL.PONE.0172175
PubMed: 28249009 | | 2017-03-01 |
| IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation | [1]Costin Tomescu, [2]Pablo Tebas, [3]Luis J Montaner [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0000000000001380
PubMed: 28225449 | | 2017-03-01 |
| Effect of HIV Antibody VRC01 on Viral Rebound after Treatment Interruption | [1]Katharine J Bar, [2]Michael C. Sneller, [3]Linda J Harrison, [4]J Shawn Justement, [5]Edgar T Overton, [6]Mary E Petrone, [7]D Brenda Salantes, [8]Catherine A Seamon, [9]Benjamin Scheinfeld, [10]Richard W Kwan, ..., [35]James A Hoxie, [36]Anthony Fauci, [37]Pablo Tebas, [38]Tae-Wook Chun [Full author list] | The New England Journal of Medicine [curation] | DOI: 10.1056/NEJMOA1608243
PubMed: 27959728 | HIV [curation]; antibody [curation] | 2016-11-09 |
| A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults | [1]Gregory D Huhn, [2]Pablo Tebas, [3]Joel Gallant, [4]Timothy Wilkin, [5]Andrew Cheng, [6]Mingjin Yan, [7]Lijie Zhong, [8]Christian Callebaut, [9]Joseph M Custodio, [10]Marshall W Fordyce, [11]Moupali Das, [12]Scott McCallister [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0000000000001193
PubMed: 27753684 | tenofovir [curation]; emtricitabine [curation]; darunavir [curation] | 2016-10-06 |
| Brief Report: Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Adults With Renal Impairment: 96-Week Results From a Single-Arm, Multicenter, Open-Label Phase 3 Study | [1]Frank A Post, [2]Pablo Tebas, [3]Amanda Clarke, [4]Laurent Cotte, [5]William R Short, [6]Michael E Abram, [7]Shuping Jiang, [8]Andrew Cheng, [9]Moupali Das, [10]Marshall W Fordyce [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0000000000001186
PubMed: 27673443 | tenofovir [curation]; emtricitabine [curation]; cobicistat [curation]; multicenter clinical trial [curation] | 2016-09-23 |
| The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1. | [1]Jeffrey M Jacobson, [2]Steven E Bosinger, [3]Minhee Kang, [4]Pablo F Belaunzarán-Zamudio, [5]Roy M Matining, [6]Cara C Wilson, [7]Charles Flexner, [8]Brian Clagett, [9]Jill Plants, [10]Sarah Read, [11]Lynette Purdue, [12]Laurie Myers, [13]Linda Boone, [14]Pablo Tebas, [15]Princy Kumar, [16]David Clifford, [17]Daniel C Douek, [18]Guido Silvestri, [19]Alan L Landay, [20]Michael M Lederman [Full author list] | AIDS Research and Human Retroviruses [curation] | DOI: 10.1089/AID.2015.0336
PubMed: 26935044 | chloroquine [curation] | 2016-03-02 |
| Effects of once-daily darunavir/ritonavir versus atazanavir/ritonavir on insulin sensitivity in HIV-infected persons over 48 weeks: results of an exploratory substudy of METABOLIK, a phase 4, randomized trial | [1]Edgar Turner Overton, [2]Pablo Tebas, [3]Bruce Coate, [4]Robert Ryan, [5]Amy Perniciaro, [6]Yaswant K Dayaram, [7]Guy De La Rosa, [8]Bryan P Baugh [Full author list] | HIV Clinical Trials [curation] | DOI: 10.1080/15284336.2016.1141468
PubMed: 26917112 | ritonavir [curation]; atazanavir [curation]; preproinsulin [curation]; atazanavir/ritonavir [curation]; phase IV clinical trial [curation] | 2016-02-26 |
| The Safety and Immunogenicity of an Interleukin-12-Enhanced Multiantigen DNA Vaccine Delivered by Electroporation for the Treatment of HIV-1 Infection | [1]Jeffrey M Jacobson, [2]Lu Zheng, [3]Cara C Wilson, [4]Pablo Tebas, [5]Roy M Matining, [6]Michael A Egan, [7]John Eldridge, [8]Alan L Landay, [9]David B Clifford, [10]Anne F. Luetkemeyer, [11]Jennifer Tiu, [12]Ana L Martinez, [13]Jennifer Janik, [14]Teresa A Spitz, [15]John Hural, [16]Juliana McElrath, [17]Nicole Frahm, [18]ACTG A5281 Protocol Team [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0000000000000830
PubMed: 26761518 | electroporation [curation] | 2016-02-01 |
| Brief Report: A Randomized, Double-Blind Comparison of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate, Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine for Initial HIV-1 Treatment: Week 96 Results | [1]David Wohl, [2]Shinichi Oka, [3]Nathan Clumeck, [4]Amanda Clarke, [5]Cynthia Brinson, [6]Jeffrey Stephens, [7]Karen Tashima, [8]Jose R Arribas, [9]Bruce Rashbaum, [10]Antoine Cheret, [11]Jason Brunetta, [12]Cristina Mussini, [13]Pablo Tebas, [14]Paul E Sax, [15]Andrew Cheng, ... [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0000000000000940
PubMed: 26829661 | tenofovir [curation]; emtricitabine [curation]; cobicistat [curation] | 2016-01-29 |
| Mechanisms of bone disease in HIV and hepatitis C virus: impact of bone turnover, tenofovir exposure, sex steroids and severity of liver disease | [1]Roger Bedimo, [2]James Cutrell, [3]Song Zhang, [4]Henning Drechsler, [5]Ang Gao, [6]Geri Brown, [7]Irfan Farukhi, [8]Rosinda Castanon, [9]Pablo Tebas, [10]Naim M. Maalouf [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0000000000000952
PubMed: 26558726 | tenofovir [curation]; Hepatitis C virus [curation]; bone disease [curation] | 2015-11-10 |
| Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected Patients | [1]Roger Bedimo, [2]Minhee Kang, [3]Pablo Tebas, [4]Edgar T Overton, [5]Kimberly Hollabaugh, [6]Grace Mccomsey, [7]Debika Bhattacharya, [8]Christopher Evans, [9]Todd T Brown, [10]Babafemi Taiwo [Full author list] | AIDS Research and Human Retroviruses [curation] | DOI: 10.1089/AID.2015.0204
PubMed: 26499270 | ribavirin [curation]; Hepatitis C virus [curation] | 2015-10-23 |
| Obesity Is Not Associated with Impaired Immune Response to Influenza Vaccination in HIV-Infected Persons | [1]Charitha Gowda, [2]Noah McKittrick, [3]Deborah Kim, [4]Rosemarie A Kappes, [5]Vincent Lo Re, [6]Pablo Tebas [Full author list] | AIDS Research and Treatment [curation] | DOI: 10.1155/2015/653840
PubMed: 26576297 | | 2015-10-12 |
| Greater change in bone turnover markers for efavirenz/emtricitabine/tenofovir disoproxil fumarate versus dolutegravir + abacavir/lamivudine in antiretroviral therapy-naive adults over 144 weeks | [1]Pablo Tebas, [2]Princy Kumar, [3]Charles Hicks, [4]Catherine Granier, [5]Brian Wynne, [6]Sherene Min, [7]Keith Pappa [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0000000000000863
PubMed: 26355674 | tenofovir [curation]; emtricitabine [curation]; efavirenz [curation]; dolutegravir [curation]; abacavir/lamivudine [curation]; anti-retroviral agent [curation] | 2015-09-09 |
| Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1. | [1]Susanna Naggie, [2]Curtis L Cooper, [3]Michael Saag, [4]Kimberly Workowski, [5]Peter Ruane, [6]William J Towner, [7]Kristen Marks, [8]Anne F. Luetkemeyer, [9]Rachel P Baden, [10]Paul E Sax, ..., [23]Dushyantha Jayaweera, [24]Amy E Colson, [25]Pablo Tebas, [26]David K Wong, [27]Douglas T Dieterich, ... [Full author list] | The New England Journal of Medicine [curation] | DOI: 10.1056/NEJMOA1501315
PubMed: 26196665 | sofosbuvir [curation]; ledipasvir [curation] | 2015-07-21 |
| Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation: A Randomized Trial | [1]Edgar Turner Overton, [2]Ellen S Chan, [3]Todd T Brown, [4]Pablo Tebas, [5]Grace Mccomsey, [6]Kathleen M Melbourne, [7]Andrew Napoli, [8]William Royce Hardin, [9]Heather J Ribaudo, [10]Michael T Yin [Full author list] | Annals of Internal Medicine [curation] | DOI: 10.7326/M14-1409
PubMed: 26075752 | vitamin D [curation]; anti-retroviral agent [curation] | 2015-06-01 |
| Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults | [1]Pablo Tebas, [2]Sergei Spitsin, [3]Jeffrey S Barrett, [4]Florin Tuluc, [5]Okan Elci, [6]James J Korelitz, [7]Wayne Wagner, [8]Angela Winters, [9]Deborah Kim, [10]Renae Catalano, [11]Dwight L Evans, [12]Steven D Douglas [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0000000000000638
PubMed: 25915168 | | 2015-05-01 |
| Superior outcomes in HIV-positive kidney transplant patients compared with HCV-infected or HIV/HCV-coinfected recipients | [1]Deirdre Sawinski, [2]Kimberly A Forde, [3]Kevin Eddinger, [4]Andrea B. Troxel, [5]Emily Blumberg, [6]Pablo Tebas, [7]Peter L Abt, [8]Roy D Bloom [Full author list] | Kidney International [curation] | DOI: 10.1038/KI.2015.74
PubMed: 25807035 | HIV [curation] | 2015-03-25 |
| Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women | [1]Vincent Lo Re, [2]Kenneth Lynn, [3]Emily R Stumm, [4]Jin Long, [5]Melissa S Nezamzadeh, [6]Joshua F Baker, [7]Andrew N Hoofnagle, [8]Angela J Kapalko, [9]Karam Mounzer, [10]Babette S Zemel, [11]Pablo Tebas, [12]Jay R Kostman, [13]Mary B Leonard [Full author list] | Journal of Infectious Diseases [curation] | DOI: 10.1093/INFDIS/JIV147
PubMed: 25754980 | | 2015-03-09 |
| Synthetic consensus HIV-1 DNA induces potent cellular immune responses and synthesis of granzyme B, perforin in HIV infected individuals | [1]Matthew P Morrow, [2]Pablo Tebas, [3]Jian Yan, [4]Lorenzo Ramirez, [5]Anna Slager, [6]Kim Kraynyak, [7]Malissa Diehl, [8]Divya Shah, [9]Amir Khan, [10]Jessica Lee, [11]Jean Boyer, [12]J Joseph Kim, [13]Niranjan Y Sardesai, [14]David B. Weiner, [15]Mark L Bagarazzi [Full author list] | Molecular Therapy [curation] | DOI: 10.1038/MT.2014.245
PubMed: 25531694 | | 2014-12-22 |
| The RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone health | [1]Roger J Bedimo, [2]Henning Drechsler, [3]Mamta Jain, [4]James Cutrell, [5]Song Zhang, [6]Xilong Li, [7]Irfan Farukhi, [8]Rosinda Castanon, [9]Pablo Tebas, [10]Naim M. Maalouf [Full author list] | PLOS One [curation] | DOI: 10.1371/JOURNAL.PONE.0106221
PubMed: 25170938 | tenofovir [curation]; patient [curation]; raltegravir [curation]; emtricitabine [curation]; tenofovir/emtricitabine [curation]; darunavir [curation]; anti-retroviral agent [curation] | 2014-08-29 |
| High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART | [1]L A Ramirez, [2]T A Arango, [3]E Thompson, [4]M Naji, [5]Pablo Tebas, [6]J D Boyer [Full author list] | Journal of Leukocyte Biology [curation] | DOI: 10.1189/JLB.3A0414-232RR
PubMed: 25157027 | | 2014-08-25 |
| A randomized controlled trial of palifermin (recombinant human keratinocyte growth factor) for the treatment of inadequate CD4+ T-lymphocyte recovery in patients with HIV-1 infection on antiretroviral therapy | [1]Jeffrey M Jacobson, [2]Hongying Wang, [3]Rebeka Bordi, [4]Lu Zheng, [5]Barry H Gross, [6]Alan L Landay, [7]John Spritzler, [8]Jean-Pierre Routy, [9]Constance Benson, [10]Judith Aberg, [11]Pablo Tebas, [12]David W Haas, [13]Jennifer Tiu, [14]Kristine Coughlin, [15]Lynette Purdue, [16]Rafick-Pierre Sékaly, [17]AIDS Clinical Trials Group (ACTG) A5212 Protocol Team [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0000000000000195
PubMed: 24815851 | keratinocyte [curation] | 2014-08-01 |
| Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week res | [1]Jose R. Arribas, [2]Gilles Pialoux, [3]Joseph C Gathe, [4]Giovanni Di Perri, [5]Jacques Reynes, [6]Pablo Tebas, [7]Thai Nguyen, [8]Ramin Ebrahimi, [9]Kirsten White, [10]David Piontkowsky [Full author list] | Lancet Infectious Diseases [curation] | DOI: 10.1016/S1473-3099(14)70782-0
PubMed: 24908551 | virology [curation]; tenofovir [curation]; emtricitabine [curation]; ritonavir [curation]; cobicistat [curation] | 2014-06-05 |
| Randomized, placebo-controlled, single-ascending-dose study of BMS-791325, a hepatitis C virus (HCV) NS5B polymerase inhibitor, in HCV genotype 1 infection | [1]Karen D Sims, [2]Julie Lemm, [3]Timothy Eley, [4]Menping Liu, [5]Anna Berglind, [6]Diane Sherman, [7]Eric Lawitz, [8]Apinya B Vutikullird, [9]Pablo Tebas, [10]Min Gao, [11]Claudio Pasquinelli, [12]Dennis M Grasela [Full author list] | Antimicrobial Agents and Chemotherapy [curation] | DOI: 10.1128/AAC.02579-13
PubMed: 24733462 | hepatitis C [curation]; placebo [curation]; Hepatitis C virus [curation] | 2014-04-14 |
| Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-Infected adults treated with rilpivirine or Efavirenz for 96 weeks in the ECHO and THRIVE trials | [1]Pablo Tebas, [2]Michael Sension, [3]Jose R. Arribas, [4]Dan Duiculescu, [5]Eric Florence, [6]Chien-Ching Hung, [7]Timothy Wilkin, [8]Simon Vanveggel, [9]Marita Stevens, [10]Henri Deckx, [11]ECHO and THRIVE Study Groups [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1093/CID/CIU234
PubMed: 24729492 | efavirenz [curation] | 2014-04-11 |
| Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells | [1]Lorenzo A Ramirez, [2]Alexander Daniel, [3]Ian Frank, [4]Pablo Tebas, [5]Jean D Boyer [Full author list] | Journal of Infectious Diseases [curation] | DOI: 10.1093/INFDIS/JIU132
PubMed: 24610877 | | 2014-03-08 |
| Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV | [1]Pablo Tebas, [2]David Stein, [3]Winson W Tang, [4]Ian Frank, [5]Shelley Q Wang, [6]Gary Lee, [7]S Kaye Spratt, [8]Richard T Surosky, [9]Martin A Giedlin, [10]Geoff Nichol, [11]Michael C Holmes, [12]Philip D Gregory, [13]Dale G Ando, [14]Michael Kalos, [15]Ronald G Collman, [16]Gwendolyn Binder-Scholl, [17]Gabriela Plesa, [18]Wei-Ting Hwang, [19]Bruce L. Levine, [20]Carl H. June [Full author list] | The New England Journal of Medicine [curation] | DOI: 10.1056/NEJMOA1300662
PubMed: 24597865 | HIV [curation] | 2014-03-06 |
| Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants | [1]Frank J. Palella, [2]Martin Fisher, [3]Pablo Tebas, [4]Brian Gazzard, [5]Peter Ruane, [6]Jan Van Lunzen, [7]David Shamblaw, [8]Jason Flamm, [9]Ramin Ebrahimi, [10]Danielle P Porter, [11]Kirsten White, [12]Jason Hindman, [13]Elizabeth Elbert, [14]Shampa De-Oertel, [15]Todd Fralich [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0000000000000087
PubMed: 24670520 | tenofovir [curation]; emtricitabine [curation]; ritonavir [curation]; anti-retroviral agent [curation] | 2014-01-01 |
| Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitant. | [1]Jeffrey S Barrett, [2]Gaurav Bajaj, [3]Jennifer McGuire, [4]Di Wu, [5]Sergei Spitsin, [6]Ganesh Moorthy, [7]Xianguo Zhao, [8]Pablo Tebas, [9]Dwight L Evans, [10]Steven D Douglas [Full author list] | Current HIV Research [curation] | DOI: 10.2174/1570162X12666140526120831
PubMed: 24862330 | | 2014-01-01 |
| Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients | [1]Naim M. Maalouf, [2]Song Zhang, [3]Henning Drechsler, [4]Geri R Brown, [5]Pablo Tebas, [6]Roger Bedimo [Full author list] | Journal of Bone and Mineral Research [curation] | DOI: 10.1002/JBMR.1988
PubMed: 23677838 | osteoporosis [curation]; liver disease [curation] | 2013-12-01 |
| Comparison of cardiovascular disease risk markers in HIV-infected patients receiving abacavir and tenofovir: the nucleoside inflammation, coagulation and endothelial function (NICE) study | [1]David A Wohl, [2]Gretchen Arnoczy, [3]Carl Fichtenbaum, [4]Thomas Campbell, [5]Babafemi Taiwo, [6]Charles Hicks, [7]Grace Mccomsey, [8]Susan L Koletar, [9]Paul E Sax, [10]Pablo Tebas, [11]Belinda Ha, [12]Kelly Massengale, [13]Kendall K Walsh, [14]James H Stein [Full author list] | Antiviral Therapy [curation] | DOI: 10.3851/IMP2681
PubMed: 23985706 | endothelium [curation]; tenofovir [curation]; abacavir [curation]; cardiovascular disease [curation] | 2013-08-28 |
| Low baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiation | [1]Philip M Grant, [2]Douglas Kitch, [3]Grace Mccomsey, [4]Michael P Dube, [5]Richard Haubrich, [6]Jeannie S Huang, [7]Sharon Riddler, [8]Pablo Tebas, [9]Andrew R Zolopa, [10]Ann C Collier, [11]Todd T Brown [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1093/CID/CIT538
PubMed: 23943825 | anti-retroviral agent [curation] | 2013-08-13 |
| Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density | [1]Kristine Erlandson, [2]Douglas Kitch, [3]Camlin Tierney, [4]Paul E Sax, [5]Eric S Daar, [6]Pablo Tebas, [7]Kathleen Melbourne, [8]Belinda Ha, [9]Nasreen C Jahed, [10]Grace Mccomsey [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0B013E328361D25D
PubMed: 24384588 | anti-retroviral agent [curation] | 2013-08-01 |
| In vitro and in vivo effects of IGF-I on adiposity in HIV-associated metabolic disease: a pilot study | [1]Roy J Kim, [2]Sumit Vaghani, [3]Larisa M Zifchak, [4]Joseph H Quinn, [5]Weimian He, [6]Pablo Tebas, [7]Ian Frank [Full author list] | Archives of Medical Research [curation] | DOI: 10.1016/J.ARCMED.2013.06.001
PubMed: 23867790 | metabolic disease [curation] | 2013-07-16 |
| Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers | [1]Malissa C Diehl, [2]Jessica C Lee, [3]Stephen E Daniels, [4]Pablo Tebas, [5]Amir S Khan, [6]Mary Giffear, [7]Niranjan Y Sardesai, [8]Mark L Bagarazzi [Full author list] | Human Vaccines & Immunotherapeutics [curation] | DOI: 10.4161/HV.24702
PubMed: 24051434 | electroporation [curation] | 2013-06-04 |
| Improved treatment for primary HIV infection by interferon-alfa therapy? Does HCV treatment in HIV/HCV coinfected patients help us to test this hypothesis? Reply to zur Wiesch and van Lunzen | [1]Livio Azzoni, [2]Andrea S Foulkes, [3]Emmanouil Papasavvas, [4]Angela M Mexas, [5]Kenneth M Lynn, [6]Karam Mounzer, [7]Pablo Tebas, [8]Jeffrey M Jacobson, [9]Ian Frank, [10]Una O'Doherty, [11]Jay Kostman, [12]Luis J Montaner [Full author list] | Journal of Infectious Diseases [curation] | DOI: 10.1093/INFDIS/JIT160
PubMed: 23570845 | | 2013-04-09 |
| Increased fracture risk with HIV infection--a growing concern | [1]Roger Bedimo, [2]Pablo Tebas [Full author list] | Nature Reviews Endocrinology [curation] | DOI: 10.1038/NRENDO.2013.62
PubMed: 23529040 | | 2013-03-26 |
| Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death | [1]E T Overton, [2]D Kitch, [3]C A Benson, [4]P W Hunt, [5]James H Stein, [6]M Smurzynski, [7]H J Ribaudo, [8]Pablo Tebas [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1093/CID/CIT053
PubMed: 23386631 | statin therapy [curation] | 2013-02-05 |
| Patient monitoring and follow-up in lentiviral clinical trials | [1]Gerard J McGarrity, [2]Gloria Hoyah, [3]April Winemiller, [4]Kris Andre, [5]David Stein, [6]Gary Blick, [7]Richard N Greenberg, [8]Clifford Kinder, [9]Andrew Zolopa, [10]Gwen Binder-Scholl, [11]Pablo Tebas, [12]Carl H. June, [13]Laurent M Humeau, [14]Tessio Rebello [Full author list] | Journal of Gene Medicine [curation] | DOI: 10.1002/JGM.2691
PubMed: 23322669 | patient [curation] | 2013-02-01 |
| Early versus delayed antiretroviral therapy and cerebrospinal fluid fungal clearance in adults with HIV and cryptococcal meningitis | [1]Gregory P Bisson, [2]Mooketsi Molefi, [3]Scarlett Bellamy, [4]Rameshwari Thakur, [5]Andrew P Steenhoff, [6]Neo Tamuhla, [7]Tumelo Rantleru, [8]Irene Tsimako, [9]Stephen J. Gluckman, [10]Shruthi Ravimohan, [11]Drew Weissman, [12]Pablo Tebas [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1093/CID/CIT019
PubMed: 23362285 | HIV [curation]; meningitis [curation]; cerebrospinal fluid [curation]; anti-retroviral agent [curation] | 2013-01-29 |
| Antiviral effects of autologous CD4 T cells genetically modified with a conditionally replicating lentiviral vector expressing long antisense to HIV | [1]Pablo Tebas, [2]David Stein, [3]Gwendolyn Binder-Scholl, [4]Rithun Mukherjee, [5]Troy Brady, [6]Tessio Rebello, [7]Laurent Humeau, [8]Michael Kalos, [9]Emmanouil Papasavvas, [10]Luis J Montaner, ... [Full author list] | Blood [curation] | DOI: 10.1182/BLOOD-2012-07-447250
PubMed: 23264589 | | 2012-12-20 |
| Metabolic syndrome before and after initiation of antiretroviral therapy in treatment-naive HIV-infected individuals | [1]Supriya Krishnan, [2]Jeffrey T Schouten, [3]Benjamin Atkinson, [4]Todd Brown, [5]David Wohl, [6]Grace Mccomsey, [7]Marshall J Glesby, [8]Cecilia Shikuma, [9]Richard Haubrich, [10]Pablo Tebas, [11]Thomas B Campbell, [12]Denise L Jacobson [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0B013E3182690E3C
PubMed: 22828718 | HIV [curation]; metabolic syndrome [curation]; anti-retroviral agent [curation] | 2012-11-01 |
| Pegylated Interferon alfa-2a monotherapy results in suppression of HIV type 1 replication and decreased cell-associated HIV DNA integration | [1]Livio Azzoni, [2]Andrea S Foulkes, [3]Emmanouil Papasavvas, [4]Angela M Mexas, [5]Kenneth M Lynn, [6]Karam Mounzer, [7]Pablo Tebas, [8]Jeffrey M Jacobson, [9]Ian Frank, [10]Michael P. Busch, [11]Steven G Deeks, [12]Mary Carrington, [13]Una O'Doherty, [14]Jay Kostman, [15]Luis J Montaner [Full author list] | Journal of Infectious Diseases [curation] | DOI: 10.1093/INFDIS/JIS663
PubMed: 23105144 | HIV [curation]; pegylated interferon [curation] | 2012-10-26 |
| Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection | [1]Vincent Lo Re, [2]Jessica Volk, [3]Craig W Newcomb, [4]Yu-Xiao Yang, [5]Cristin P Freeman, [6]Sean Hennessy, [7]Jay R Kostman, [8]Pablo Tebas, [9]Mary B Leonard, [10]A Russell Localio [Full author list] | Hepatology [curation] | DOI: 10.1002/HEP.25866
PubMed: 22619086 | bone fracture [curation]; hepatitis C [curation]; Hepatitis C virus [curation] | 2012-10-14 |
| Vitamin D Levels, Natural H1N1 Infection and Response to H1N1 Vaccine among HIV-Infected Individuals | [1]Florence Momplaisir, [2]Ian Frank, [3]Wa Meyer, [4]Deborah Kim, [5]Rosemary Kappes, [6]Pablo Tebas [Full author list] | Journal of AIDS & clinical research [curation] | DOI: 10.4172/2155-6113.1000152
PubMed: 23227442 | vitamin D [curation] | 2012-05-01 |
| Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials | [1]Mark Nelson, [2]Gerardo Amaya, [3]Nathan Clumeck, [4]Clovis Arns da Cunha, [5]Dushyantha Jayaweera, [6]Patrice Junod, [7]Taisheng Li, [9]Marita Stevens, [10]Annemie Buelens, [11]Simon Vanveggel, [12]Katia Boven, [13]ECHO and THRIVE Study Groups, [3-Q47158666]Nathan Clumeck, [8]Pablo Tebas [Full author list] | Journal of Antimicrobial Chemotherapy [curation] | DOI: 10.1093/JAC/DKS130
PubMed: 22532465 | Hepatitis B virus [curation]; Hepatitis C virus [curation]; phase III clinical trial [curation] | 2012-04-24 |
| Metabolic effects of darunavir/ritonavir versus atazanavir/ritonavir in treatment-naive, HIV type 1-infected subjects over 48 weeks | [1]Judith Aberg, [2]Pablo Tebas, [3]Edgar Turner Overton, [4]Samir K Gupta, [5]Paul E Sax, [6]Alan Landay, [7]Ron Falcon, [8]Robert Ryan, [9]Guy De La Rosa [Full author list] | AIDS Research and Human Retroviruses [curation] | DOI: 10.1089/AID.2011.0327
PubMed: 22352336 | ritonavir [curation]; atazanavir [curation]; atazanavir/ritonavir [curation] | 2012-04-02 |
| Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents. | [1]Roger Bedimo, [2]Naim M. Maalouf, [3]Song Zhang, [4]Henning Drechsler, [5]Pablo Tebas [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0B013E32835192AE
PubMed: 22301411 | bone fracture [curation]; tenofovir [curation]; osteoporosis [curation]; anti-retroviral agent [curation] | 2012-04-01 |
| Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptions | [1]Baligh R Yehia, [2]Judith A Long, [3]Cordelia R Stearns, [4]Benjamin French, [5]Pablo Tebas, [6]Ian Frank [Full author list] | AIDS Care [curation] | DOI: 10.1080/09540121.2011.630368
PubMed: 22106980 | | 2011-11-22 |
| Disease-modifying therapeutic concepts for HIV in the era of highly active antiretroviral therapy | [1]Scott L Butler, [2]Hernan Valdez, [3]Michael Westby, [4]Manos Perros, [5]Carl H. June, [6]Jeffrey M Jacobson, [7]Yves Levy, [8]David A Cooper, [9]Daniel Douek, [10]Michael M Lederman, [11]Pablo Tebas [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0B013E31822CCFCC
PubMed: 21792065 | anti-retroviral agent [curation] | 2011-11-01 |
| Risk factors for medication non-adherence in an HIV infected population in the Dominican Republic | [1]Julian Harris, [2]Mara Pillinger, [3]Deborah Fromstein, [4]Bayardo Gomez, [5]Ivelisse Garris, [6]Peter A Kanetsky, [7]Pablo Tebas, [8]Robert Gross [Full author list] | AIDS and Behavior [curation] | DOI: 10.1007/S10461-010-9781-1
PubMed: 20721615 | Dominican Republic [curation] | 2011-10-01 |
| HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells | [1]Karuppiah Muthumani, [2]Devon J Shedlock, [3]Daniel K Choo, [4]Paolo Fagone, [5]Omkar U Kawalekar, [6]Jonathan Goodman, [7]Chaoran B Bian, [8]Aarti A Ramanathan, [9]Parikh Atman, [10]Pablo Tebas, [11]Michael A Chattergoon, [12]Andrew Y Choo, [13]David B. Weiner [Full author list] | Journal of Immunology [curation] | DOI: 10.4049/JIMMUNOL.1100594
PubMed: 21856939 | | 2011-08-19 |
| Effects of the H2-receptor antagonist famotidine on the pharmacokinetics of atazanavir-ritonavir with or without tenofovir in HIV-infected patients | [1]Xiaodong Wang, [2]Marta Boffito, [3]Jenny Zhang, [4]Ellen Chung, [5]Li Zhu, [6]Yaoshi Wu, [7]Kristine Patterson, [8]Angela Kashuba, [9]Pablo Tebas, [10]Michael Child, [11]Lisa Mahnke, [12]Richard Bertz [Full author list] | AIDS Patient Care and STDs [curation] | DOI: 10.1089/APC.2011.0113
PubMed: 21770762 | tenofovir [curation]; pharmacokinetics [curation]; famotidine [curation]; ritonavir [curation]; atazanavir [curation] | 2011-07-19 |
| Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s | [1]Grace Mccomsey, [2]Douglas Kitch, [3]Paul E Sax, [4]Pablo Tebas, [5]Camlin Tierney, [6]Nasreen C Jahed, [7]Laurie Myers, [8]Kathleen Melbourne, [9]Belinda Ha, [10]Eric S Daar [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1093/CID/CIR324
PubMed: 21690627 | tenofovir [curation]; emtricitabine [curation]; ritonavir [curation]; efavirenz [curation]; atazanavir [curation] | 2011-07-01 |
| Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era. | [1]Roger J Bedimo, [2]Andrew O Westfall, [3]Henning Drechsler, [4]Gabriela Vidiella, [5]Pablo Tebas [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1093/CID/CIR269
PubMed: 21653308 | myocardial infarction [curation]; abacavir [curation]; acute myocardial infarction [curation]; anti-retroviral agent [curation] | 2011-07-01 |
| Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy o | [1]Grace Mccomsey, [2]Douglas Kitch, [3]Eric S Daar, [4]Camlin Tierney, [5]Nasreen C Jahed, [6]Pablo Tebas, [7]Laurie Myers, [8]Kathleen Melbourne, [9]Belinda Ha, [10]Paul E Sax [Full author list] | Journal of Infectious Diseases [curation] | DOI: 10.1093/INFDIS/JIR188
PubMed: 21606537 | bone fracture [curation]; tenofovir [curation]; emtricitabine [curation]; ritonavir [curation]; efavirenz [curation]; atazanavir [curation]; anti-retroviral agent [curation] | 2011-06-01 |
| Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection. | [1]Zsofia Szep, [2]Giovanni Guaraldi, [3]Samir S. Shah, [4]Vincent Lo Re, [5]Sarah J. Ratcliffe, [6]Gabriella Orlando, [7]Federica Carli, [8]Rosario Rossi, [9]Vincenzo Rochira, [10]Pablo Tebas [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0B013E328342FDFD
PubMed: 21178753 | vitamin D [curation]; vitamin deficiency [curation]; type 2 diabetes [curation]; vitamin D deficiency [curation] | 2011-02-01 |
| A randomized, placebo controlled, double masked phase IB study evaluating the safety and antiviral activity of aprepitant, a neurokinin-1 receptor antagonist in HIV-1 infected adults | [1]Pablo Tebas, [2]Florin Tuluc, [3]Jeffrey S Barrett, [4]Wayne Wagner, [5]Deborah Kim, [6]Huaquing Zhao, [7]René Gonin, [8]James Korelitz, [9]Steven D Douglas [Full author list] | PLOS One [curation] | DOI: 10.1371/JOURNAL.PONE.0024180
PubMed: 21931661 | placebo [curation] | 2011-01-01 |
| European mitochondrial DNA haplogroups and metabolic changes during antiretroviral therapy in AIDS Clinical Trials Group Study A5142 | [1]Todd M. Hulgan, [2]Richard Haubrich, [3]Sharon A Riddler, [4]Pablo Tebas, [5]Marylyn D. Ritchie, [6]Grace Mccomsey, [7]David W. Haas, [8]Jeffrey A Canter [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0B013E32833F9D02
PubMed: 20871389 | mitochondrial DNA [curation]; anti-retroviral agent [curation] | 2011-01-01 |
| Anti-HIV-1 activity of the neurokinin-1 receptor antagonist aprepitant and synergistic interactions with other antiretrovirals | [1]Mark M. Manak, [2]Dmitry A Moshkoff, [3]Lequan T Nguyen, [4]John Meshki, [5]Pablo Tebas, [6]Florin Tuluc, [7]Steven D Douglas [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0B013E3283405C33
PubMed: 20975512 | | 2010-11-01 |
| Bone disease in HIV infection: a practical review and recommendations for HIV care providers | [1]Grace Mccomsey, [2]Pablo Tebas, [3]Elizabeth Shane, [4]Michael T Yin, [5]E Turner Overton, [6]Jeannie S Huang, [7]Grace M Aldrovandi, [8]Sandra W Cardoso, [9]Jorge L Santana, [10]Todd T Brown [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1086/656412
PubMed: 20839968 | HIV [curation]; bone disease [curation] | 2010-10-01 |
| Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals | [1]Pablo Tebas, [2]Ian Frank, [3]Mark Lewis, [4]Joseph Quinn, [5]Larisa Zifchak, [6]Aleshia Thomas, [7]Thomas Kenney, [8]Rosemary Kappes, [9]Wayne Wagner, [10]Kathy Maffei, [11]Kathleen E. Sullivan, [12]Center for AIDS Research and Clinical Trials Unit of the University of Pennsylvania [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0B013E32833C6D5C
PubMed: 20616698 | vaccine [curation] | 2010-09-01 |
| Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200 | [1]Michael F Para, [2]Jeff Schouten, [3]Susan L Rosenkranz, [4]Song Yu, [5]David B. Weiner, [6]Pablo Tebas, [7]C Jo White, [8]Dominic N. Reeds, [9]Juan Lertora, [10]Kristine B Patterson, [11]Eric S Daar, [12]Winston Cavert, [13]Barbara Brizz, [14]ACTG A5200 Team of the ACTG [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0B013E3181D142CB
PubMed: 20130470 | HIV [curation]; mifepristone [curation]; phase I clinical trial [curation]; phase II clinical trial [curation] | 2010-04-01 |
| Aging and HIV infection: a comparison between older HIV-infected persons and the general population | [1]Nur F Onen, [2]E Turner Overton, [3]Warren Seyfried, [4]Emily R Stumm, [5]Mariea Snell, [6]Kristin Mondy, [7]Pablo Tebas [Full author list] | HIV Clinical Trials [curation] | DOI: 10.1310/HCT1102-100
PubMed: 20542846 | HIV [curation] | 2010-03-01 |
| Hepatitis C virus treatment: The beginning of a new era | [1]Pablo Tebas [Full author list] | Current HIV/AIDS reports [curation] | DOI: 10.1007/S11904-009-0023-Y
| Hepatitis C virus [curation] | 2009-07-14 |
| Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110 | [1]Pablo Tebas, [2]J Zhang, [3]R Hafner, [4]K Tashima, [5]A Shevitz, [6]Kevin Yarasheski, [7]B Berzins, [8]S Owens, [9]J Forand, [10]S Evans, [11]Robert L. Murphy [Full author list] | Journal of Antimicrobial Chemotherapy [curation] | DOI: 10.1093/JAC/DKP071
PubMed: 19299471 | lipoatrophy [curation] | 2009-03-19 |
| Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cells | [1]Gary P Wang, [2]Bruce L. Levine, [3]Gwendolyn K Binder, [4]Charles C Berry, [5]Nirav Malani, [6]Gary McGarrity, [7]Pablo Tebas, [8]Carl H. June, [9]Frederic D. Bushman [Full author list] | Molecular Therapy [curation] | DOI: 10.1038/MT.2009.16
PubMed: 19259065 | | 2009-03-03 |
| Hyperhomocysteinaemia in HIV-infected patients: determinants of variability and correlations with predictors of cardiovascular disease | [1]Giovanni Guaraldi, [2]P Ventura, [3]E Garlassi, [4]G Orlando, [5]Nicola Squillace, [6]G Nardini, [7]C Stentarelli, [8]S Zona, [9]S Marchini, [10]V Moriondo, [11]Pablo Tebas [Full author list] | HIV Medicine [curation] | DOI: 10.1111/J.1468-1293.2008.00649.X
PubMed: 19125962 | | 2009-01-01 |
| Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection | [1]Gerd Fätkenheuer, ..., [2]Mark Nelson, [3]Adriano Lazzarin, [4]Irina Konourina, [5]Andy I M Hoepelman, [6]Harry Lampiris, [7]Bernard Hirschel, [8]Pablo Tebas, [9]François Raffi, [10]Benoit Trottier, ... [Full author list] | The New England Journal of Medicine [curation] | DOI: 10.1056/NEJMOA0803154
PubMed: 18832245 | | 2008-10-01 |
| The use of HAART is associated with decreased risk of death during initial treatment of cryptococcal meningitis in adults in Botswana | [1]Gregory P Bisson, [2]Rudo Nthobatsong, [3]Rameshwari Thakur, [4]Gloria Lesetedi, [5]Kavita Vinekar, [6]Pablo Tebas, [7]John E Bennett, [8]Stephen J. Gluckman, [9]Tendani Gaolathe, [10]Rob R MacGregor [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0B013E318183181E
PubMed: 18769344 | Botswana [curation]; meningitis [curation]; cryptococcal meningitis [curation] | 2008-10-01 |
| Human immunodeficiency virus type 1 Nef induces programmed death 1 expression through a p38 mitogen-activated protein kinase-dependent mechanism | [1]Karuppiah Muthumani, [2]Andrew Y Choo, [3]Devon J Shedlock, [4]Dominick J Laddy, [5]Senthil G Sundaram, [6]Lauren Hirao, [7]Ling Wu, [8]Khanh P Thieu, [9]Christopher W Chung, [10]Karthikbabu M Lankaraman, [11]Pablo Tebas, [12]Guido Silvestri, [13]David B. Weiner [Full author list] | Journal of Virology [curation] | DOI: 10.1128/JVI.00485-08
PubMed: 18799583 | | 2008-09-17 |
| Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options | [1]Pablo Tebas [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0B013E31818651E6
PubMed: 18725817 | HIV [curation]; patient [curation]; pathogenesis [curation]; insulin resistance [curation]; preproinsulin [curation]; prevention of HIV/AIDS [curation]; anti-retroviral agent [curation] | 2008-09-01 |
| HIV and Cardiometabolic Abnormalities: New Perspectives and Treatment Update | [1]Pablo Tebas [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0B013E3181865113
PubMed: 18725815 | | 2008-09-01 |
| Genetic analysis implicates resistin in HIV lipodystrophy | [1]Koustubh Ranade, [2]William J Geese, [3]Mustafa Noor, [4]Oliver Flint, [5]Pablo Tebas, [6]Kathleen Mulligan, [7]William Powderly, [8]Steven K Grinspoon, [9]Michael P Dube [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0B013E32830A9886
PubMed: 18670214 | | 2008-08-01 |
| Massively parallel pyrosequencing in HIV research | [1]Frederic D. Bushman, [2]Christian Hoffmann, [3]Keshet Ronen, [4]Nirav Malani, [5]Nana Minkah, [6]Heather Marshall Rose, [7]Pablo Tebas, [8]Gary P Wang [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0B013E3282FC972E
PubMed: 18614863 | HIV [curation]; pyrosequencing [curation] | 2008-07-01 |
| Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk | [1]Pablo Tebas, [2]William Keith Henry, [3]Roy Matining, [4]Deborah Weng-Cherng, [5]John Schmitz, [6]Hernan Valdez, [7]Nasreen Jahed, [8]Laurie Myers, [9]William G Powderly, [10]David Katzenstein [Full author list] | PLOS One [curation] | DOI: 10.1371/JOURNAL.PONE.0002021
PubMed: 18431498 | circulatory system [curation] | 2008-04-23 |
| Hemochromatosis gene polymorphisms, mitochondrial haplogroups, and peripheral lipoatrophy during antiretroviral therapy | [1]Todd M. Hulgan, [10-Q91413557]Asha Kallianpur, [2]Pablo Tebas, [3]Jeffrey A Canter, [4]Kathleen Mulligan, [5]David W Haas, [6]Michael Dubé, [7]Steven Grinspoon, [8]Gregory K Robbins, [9]Alison Motsinger-Reif, [10]Antonio Chiesi, [11]AIDS Clinical Trials Group 384 and A5005s Study Teams [Full author list] | Journal of Infectious Diseases [curation] | DOI: 10.1086/528697
PubMed: 18419350 | lipoatrophy [curation] | 2008-03-01 |
| Enfuvirtide does not require dose adjustment in patients with chronic kidney failure: results of a pharmacokinetic study of enfuvirtide in HIV-1-infected patients with impaired kidney function | [1]Pablo Tebas, [2]Nicholas Bellos, [3]Christopher Lucasti, [4]Gary Richmond, [5]Eliot Godofsky, [6]Indravadan Patel, [7]Yu-Yuan Chiu, [8]Claire Evans, [9]Lucy Rowell, [10]Miklos Salgo [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0B013E31816237F0
PubMed: 18091608 | pharmacokinetics [curation]; kidney failure [curation]; chronic kidney failure [curation] | 2008-03-01 |
| Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. | [1]Grace Mccomsey, [2]Michelle A Kendall, [3]Pablo Tebas, [4]Susan Swindells, [5]Evelyn Hogg, [6]Beverly Alston-Smith, [7]Carol Suckow, [8]Geetha Gopalakrishnan, [9]Constance Benson, [10]David A Wohl [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0B013E3282EF961D
PubMed: 18025884 | vitamin [curation]; vitamin D [curation] | 2007-11-01 |
| Is it time to rethink the expanded-access programs for HIV infection? | [1]Valerianna Amorosa, [2]Pablo Tebas [Full author list] | Journal of Infectious Diseases [curation] | DOI: 10.1086/521368
PubMed: 17763316 | | 2007-08-24 |
| Long-Term Body Fat Outcomes in Antiretroviral-Naive Participants Randomized to Nelfinavir or Efavirenz or Both Plus Dual Nucleosides | [1]Michael P Dub??, [2]Lauren Komarow, [3]Kathleen Mulligan, [4]Steven K Grinspoon, [5]Robert A Parker, [6]Gregory K Robbins, [7]Ronenn Roubenoff, [8]Pablo Tebas [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0B013E3181142D26
PubMed: 17589373 | efavirenz [curation]; nelfinavir [curation] | 2007-08-01 |
| Effects of Potent Antiretroviral Therapy on Free Testosterone Levels and Fat-Free Mass in Men in a Prospective, Randomized Trial: A5005s, a Substudy of AIDS Clinical Trials Group Study 384 | [1]M. P. Dube, [2]R. A. Parker, [3]K. Mulligan, [4]Pablo Tebas, [5]G. K. Robbins, [6]Ronenn Roubenoff, [7]S. K. Grinspoon [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1086/518620
PubMed: 17554712 | testosterone [curation]; testosterone [curation] | 2007-07-01 |
| DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations | [1]Christian Hoffmann, [2]Nana Minkah, [3]Jeremy Leipzig, [4]Gary Wang, [5]Max Q Arens, [6]Pablo Tebas, [7]Frederic D. Bushman [Full author list] | Nucleic Acids Research [curation] | DOI: 10.1093/NAR/GKM435
PubMed: 17576693 | pyrosequencing [curation] | 2007-06-18 |
| Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s). | [1]Pablo Tebas, [2]Jiameng Zhang, [3]Kevin Yarasheski, [4]Scott Evans, [5]Margaret A Fischl, [6]Abby Shevitz, [7]Judith Feinberg, [8]Ann C Collier, [9]Cecilia M Shikuma, [10]Barbara Brizz, [11]Fred Sattler, [12]AIDS Clinical Trials Group (ACTG) [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0B013E318042E204
PubMed: 17527093 | lopinavir [curation]; ritonavir [curation]; efavirenz [curation]; randomized experiment [curation]; lopinavir/ritonavir [curation] | 2007-06-01 |
| Interventions for body habitus changes associated with HIV infection and its treatment | [1]Pablo Tebas [Full author list] | Current HIV/AIDS reports [curation] | DOI: 10.1007/S11904-007-0013-X
PubMed: 17547830 | | 2007-05-01 |
| Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults | [1]Judith S Currier, [2]Michelle A. Kendall, [3]W Keith Henry, [4]Beverly Alston-Smith, [5]Francesca J Torriani, [6]Pablo Tebas, [7]Yanjie Li, [8]Howard N Hodis [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0B013E32811EBF79
PubMed: 17502724 | | 2007-05-01 |
| Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients | [1]Vincent Lo Re, [2]Ian Frank, [3]Robert Gross, [4]Janel Dockter, [5]Jeffrey M Linnen, [6]Cristina Giachetti, [7]Pablo Tebas, [8]John Stern, [9]Marie Synnestvedt, [10]A Russell Localio, [11]Jay R Kostman, [12]Brian L Strom [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/QAI.0B013E31802EA499
PubMed: 17159655 | Hepatitis B virus [curation] | 2007-03-01 |
| The virologic, immunologic, and clinical effects of interleukin 2 with potent antiretroviral therapy in patients with moderately advanced human immunodeficiency virus infection: a randomized controlled clinical trial--AIDS Clinical Trials Group 328. | [1]Ronald Mitsuyasu, [2]Rebecca Gelman, [3]Deborah Weng Cherng, [4]Alan Landay, [5]John Fahey, [6]Richard Reichman, [7]Alejo Erice, [8]R Pat Bucy, [9]J Michael Kilby, [10]Michael M Lederman, [11]Carol D Hamilton, [12]Juan Lertora, [13]Becky L White, [14]Pablo Tebas, [15]Anne-Marie Duliege, [16]Richard B Pollard, [17]AIDS Clinical Trials Group 328 Study Team [Full author list] | JAMA Internal Medicine [curation] | DOI: 10.1001/ARCHINTE.167.6.597
PubMed: 17389292 | virology [curation] | 2007-03-01 |
| Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro | [1]Xu Wang, [2]Steven D Douglas, [3]Jian-Ping Lai, [4]Florin Tuluc, [5]Pablo Tebas, [6]Wen-Zhe Ho [Full author list] | Journal of Neuroimmune Pharmacology [curation] | DOI: 10.1007/S11481-006-9059-6
PubMed: 18040825 | | 2007-01-12 |
| Cardiovascular risks of antiretroviral therapies | [1]Kristin Mondy, [2]Pablo Tebas [Full author list] | Annual Review of Medicine [curation] | DOI: 10.1146/ANNUREV.MED.58.072905.180040
PubMed: 17217329 | anti-retroviral agent [curation] | 2007-01-01 |
| Randomized open-label trial of two simplified, class-sparing regimens following a first suppressive three or four-drug regimen | [1]Margaret A Fischl, [2]Ann C Collier, [3]A Lisa Mukherjee, [4]Judith E Feinberg, [5]Lisa M Demeter, [6]Pablo Tebas, [7]Marina Giuliano, [8]Marjorie Dehlinger, [9]Kevin Garren, [10]Barbara Brizz, [11]Roland Bassett [Full author list] | AIDS [curation] | DOI: 10.1097/QAD.0B013E328011DDFA
PubMed: 17255739 | | 2007-01-01 |
| Cyclosporin A provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: results of a randomized, controlled trial of the AIDS Clinical Trials Group A5138 | [1]Michael M Lederman, [2]Laura Smeaton, [3]Kim Y Smith, [4]Benigno Rodriguez, [5]Minya Pu, [6]Hongying Wang, [7]Anne Sevin, [8]Pablo Tebas, [9]Scott F Sieg, [10]Kathy Medvik, [11]David M. Margolis, [12]Richard Pollard, [13]Hildegund C J Ertl, [14]Hernan Valdez [Full author list] | Journal of Infectious Diseases [curation] | DOI: 10.1086/509261
PubMed: 17109339 | cyclosporine [curation]; randomized controlled trial [curation] | 2006-11-02 |
| Explaining, Predicting, and Treating HIV-Associated CD4 Cell Loss | [1]W. Keith Henry, [2]Pablo Tebas, [3]H. Clifford Lane [Full author list] | The Journal of the American Medical Association [curation] | DOI: 10.1001/JAMA.296.12.1523
PubMed: 17003402 | | 2006-09-27 |
| Current concepts in the diagnosis and management of metabolic complications of HIV infection and its therapy | [1]D A Wohl, [2]Grace Mccomsey, [3]Pablo Tebas, [4]T T Brown, [5]M J Glesby, [6]D Reeds, [7]C Shikuma, [8]K Mulligan, [9]M Dube, [10]D Wininger, [11]Jeannie S Huang, [12]M Revuelta, [13]J Currier, [14]S Swindells, [15]Carl Fichtenbaum, [16]M Basar, [17]M Tungsiripat, [18]W Meyer, [19]J Weihe, [20]C Wanke [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1086/507333
PubMed: 16886161 | | 2006-07-27 |
| Reply to Rojo and Ramos and to Vignolo et al | [1]Valerianna Amorosa, [2]Pablo Tebas [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1086/504956
| | 2006-07-01 |
| A pilot study evaluating time to CD4 T-cell count <350 cells/mm(3) after treatment interruption following antiretroviral therapy +/- interleukin 2: results of ACTG A5102 | [1]Keith Henry, [2]David Katzenstein, [3]Deborah Weng Cherng, [4]Hernan Valdez, [5]William G Powderly, [6]Michelle Blanchard Vargas, [7]Nasreen C Jahed, [8]Jeffrey M Jacobson, [9]Laurie S Myers, [10]John L Schmitz, [11]Mark Winters, [12]Pablo Tebas, [13]A5102 Study Team of the AIDS Clinical Trials Group [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/01.QAI.0000225319.59652.1E
PubMed: 16760795 | interleukins [curation] | 2006-06-01 |
| Real-time nucleic acid sequence-based amplification assay to quantify changes in mitochondrial DNA concentrations in cell cultures and blood cells from HIV-infected patients receiving antiviral therapy | [1]Eveline C Timmermans, [2]Pablo Tebas, [3]Jos P N Ruiter, [4]Ronald J A Wanders, [5]Anthony de Ronde, [6]Michel P de Baar [Full author list] | Clinical Chemistry [curation] | DOI: 10.1373/CLINCHEM.2005.062901
PubMed: 16601068 | mitochondrial DNA [curation]; mitochondrion [curation] | 2006-04-06 |
| Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial | [1]Kathleen Mulligan, [2]Robert A Parker, [3]Lauren Komarow, [4]Steven K Grinspoon, [5]Pablo Tebas, [6]Gregory K Robbins, [7]Ronenn Roubenoff, [8]Michael P Dubé [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/01.QAI.0000214811.72916.67
PubMed: 16652032 | anti-retroviral agent [curation] | 2006-04-01 |
| Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy | [1]Andrea S Foulkes, [2]David A Wohl, [3]Ian Frank, [4]Elaine Puleo, [5]Stephanie Restine, [6]Megan L Wolfe, [7]Michael P Dube, [8]Pablo Tebas, [9]Muredach P. Reilly [Full author list] | PLOS MEDICINE [curation] | DOI: 10.1371/JOURNAL.PMED.0030052
PubMed: 16417409 | lipid [curation]; anti-retroviral agent [curation] | 2006-03-01 |
| Bone disease and HIV infection. | [1]Valerianna Amorosa, [2]Pablo Tebas [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1086/498511
PubMed: 16323100 | HIV [curation]; bone disease [curation] | 2005-11-30 |
| Distinct Mechanisms of T Cell Reconstitution Can Be Identified by Estimating Thymic Volume in Adult HIV‐1 Disease | [1]Robert C. Kalayjian, [2]John Spritzler, [3]Minya Pu, [4]Alan Landay, [5]Richard B. Pollard, [6]Vicki Stocker, [7]Lena‐Al Harthi, [8]Barry H. Gross, [9]Isaac R. Francis, [10]Susan A Fiscus, [11]Pablo Tebas, [12]Ronald J. Bosch, [13]Victor Valcour, [14]Michael M. Lederman [Full author list] | Journal of Infectious Diseases [curation] | DOI: 10.1086/466527
PubMed: 16206072 | | 2005-11-01 |
| Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection | [1]Kristin Mondy, [2]William G Powderly, [3]Sherry A Claxton, [4]Kevin Yarasheski, [5]Michael Royal, [6]John S Stoneman, [7]Mary E Hoffmann, [8]Pablo Tebas [Full author list] | Journal of Acquired Immune Deficiency Syndromes [curation] | DOI: 10.1097/01.QAI.0000145352.04440.1E
PubMed: 15764959 | vitamin [curation]; osteoporosis [curation]; vitamin D [curation] | 2005-04-01 |
| Plasmid vaccination of stable HIV-positive subjects on antiviral treatment results in enhanced CD8 T-cell immunity and increased control of viral "blips". | [1]Rob Roy MacGregor, [2]Jean D Boyer, [3]Kenneth E Ugen, [4]Pablo Tebas, [5]Terry J Higgins, [6]Yaela Baine, [7]Richard B Ciccarelli, [8]Richard S Ginsberg, [9]David B. Weiner [Full author list] | Vaccine [curation] | DOI: 10.1016/J.VACCINE.2005.01.010
PubMed: 15755572 | | 2005-03-01 |
| Effects of the G190A substitution of HIV reverse transcriptase on phenotypic susceptibility of patient isolates to delavirdine | [1]Erik J Uhlmann, [2]Pablo Tebas, [3]Gregory A Storch, [4]William G Powderly, [5]Yolanda S Lie, [6]Jeannette M Whitcomb, [7]Nicholas S Hellmann, [8]Max Q Arens [Full author list] | Journal of Clinical Virology [curation] | DOI: 10.1016/J.JCV.2004.03.012
PubMed: 15465412 | | 2004-11-01 |
| Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapy | [1]Marisa T Gerber, [2]Kristin E Mondy, [3]Kevin Yarasheski, [4]Henning Drechsler, [5]Sherry Claxton, [6]John Stoneman, [7]Debra DeMarco, [8]William G Powderly, [9]Pablo Tebas [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1086/422144
PubMed: 15307011 | niacinamide [curation]; hyperlipidemia [curation]; anti-retroviral agent [curation] | 2004-07-16 |
| The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling | [1]Michael W.-H. Wang, [2]Shi Wei, [3]Roberta Faccio, [4]Sunao Takeshita, [5]Pablo Tebas, [6]William G. Powderly, [7]Steven L. Teitelbaum, [8]F. Patrick Ross [Full author list] | Journal of Clinical Investigation [curation] | DOI: 10.1172/JCI200415797
| ritonavir [curation] | 2004-07-15 |
| Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection | [1]Pablo Tebas, [2]Kevin Yarasheski, [3]Keith Henry, [4]Sherri Claxton, [5]E Kane, [6]B Bordenave, [7]Michael Klebert, [8]William G Powderly [Full author list] | AIDS Research and Human Retroviruses [curation] | DOI: 10.1089/0889222041217374
PubMed: 15242534 | virology [curation] | 2004-06-01 |
| Cure of acute hepatitis C in HIV co-infection? | [1]Maria B Ristig, [2]Pablo Tebas, [3]Iver Gandy, [4]Roula Qaqish, [5]Judith Aberg [Full author list] | Journal of Clinical Gastroenterology [curation] | DOI: 10.1097/00004836-200403000-00026
PubMed: 15128087 | | 2004-03-01 |
| Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection | [1]Jeffrey M Jacobson, [2]Michael M Lederman, [3]John Spritzler, [4]Hernan Valdez, [5]Pablo Tebas, [6]Gail Skowron, [7]Rui Wang, [8]J Brooks Jackson, [9]Lawrence Fox, [10]Alan Landay, [11]Mark J Gilbert, [12]Dorothy O'Neil, [13]Lynne Bancroft, [14]Lena Al-Harthi, [15]Mark A Jacobson, [16]Thomas C Merigan, [17]Marshall J Glesby, [18]National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group [Full author list] | Journal of Infectious Diseases [curation] | DOI: 10.1086/379899
PubMed: 14673758 | Colony stimulating factor 2 [curation] | 2003-12-09 |
| Management of chronic hepatitis B in an HIV-positive patient with 3TC-resistant hepatitis B virus | [1]Maria Ristig, [2]Henning Drechsler, [3]Jeffrey Crippin, [4]Mauricio Lisker-Melman, [5]Pablo Tebas [Full author list] | AIDS Patient Care and STDs [curation] | DOI: 10.1089/108729103322395456
PubMed: 14588080 | Hepatitis B virus [curation]; chronic hepatitis B [curation] | 2003-09-01 |
| Fat redistribution and bone abnormalities in HIV-infected patients | [1]Pablo Tebas [Full author list] | Journal of the International Association of Providers of AIDS Care [curation] | DOI: 10.1177/154510970300200202
PubMed: 12961759 | | 2003-04-01 |
| Emerging bone problems in patients infected with human immunodeficiency virus | [1]Kristin Mondy, [2]Pablo Tebas [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1086/367566
PubMed: 12652379 | | 2003-04-01 |
| HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. | [1]Mario Cozzolino, [2]Marcos Vidal, [3]Maria Vittoria Arcidiacono, [4]Pablo Tebas, [5]Kevin Yarasheski, [6]Adriana S Dusso [Full author list] | AIDS [curation] | DOI: 10.1097/00002030-200303070-00006
PubMed: 12598771 | vitamin D [curation] | 2003-03-01 |
| Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals | [1]Kristin Mondy, [2]Kevin Yarasheski, [3]William G Powderly, [4]Michael Whyte, [5]Sherry Claxton, [6]Debra DeMarco, [7]Mary Hoffmann, [8]Pablo Tebas [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1086/367569
PubMed: 12567307 | | 2003-01-29 |
| Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed | [1]Maria B Ristig, [2]Jeffrey Crippin, [3]Judith Aberg, [4]William G Powderly, [5]Mauricio Lisker-Melman, [6]Lisa Kessels, [7]Pablo Tebas [Full author list] | Journal of Infectious Diseases [curation] | DOI: 10.1086/345770
PubMed: 12447773 | Hepatitis B virus [curation]; tenofovir [curation]; lamivudine [curation]; chronic hepatitis B [curation]; chronic hepatitis [curation] | 2002-11-22 |
| Once-daily antiretroviral therapies for HIV infection: Consensus Statement of an Advisory Committee of the International Association of Physicians in AIDS Care | [1]Calvin Cohen, [2]Richard A Elion, [3]Ian Frank, [4]Patricia Kloser, [5]Renslow Sherer, [6]Kathleen E Squires, [7]Corklin Steinhart, [8]Pablo Tebas, [9]Advisory Committee of the International Association of Physicians in AIDS Care [Full author list] | Journal of the International Association of Providers of AIDS Care [curation] | DOI: 10.1177/154510970200100406
PubMed: 12942673 | | 2002-10-01 |
| Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategies | [1]Pablo Tebas, [2]Keith Henry, [3]Kristin Mondy, [4]Steven G Deeks, [5]Herman Valdez, [6]Cal Cohen, [7]William G Powderly [Full author list] | Journal of Infectious Diseases [curation] | DOI: 10.1086/342603
PubMed: 12198623 | | 2002-08-28 |
| A phase II randomized study of the virologic and immunologic effect of zidovudine + stavudine versus stavudine alone and zidovudine + lamivudine in patients with >300 CD4 cells who were antiretroviral naive (ACTG 298). | [1]Richard B Pollard, [2]Camlin Tierney, [3]Diane Havlir, [4]Pablo Tebas, [5]Lawrence Fox, [6]Laura Smeaton, [7]Douglas Richman, [8]Gerald H Friedland [Full author list] | AIDS Research and Human Retroviruses [curation] | DOI: 10.1089/088922202760072311
PubMed: 12167276 | virology [curation]; zidovudine [curation]; lamivudine [curation]; stavudine [curation] | 2002-07-01 |
| Randomized, double-blind comparison of two nelfinavir doses plus nucleosides in HIV-infected patients (Agouron study 511). | [1]Michael Saag, [2]Pablo Tebas, [3]M Sension, [4]M Conant, [5]R Myers, [6]S K Chapman, [7]R Anderson, [8]N Clendeninn, [9]Virqacept Collaborative Study Group [Full author list] | AIDS [curation] | DOI: 10.1097/00002030-200110190-00009
PubMed: 11600825 | nelfinavir [curation] | 2001-10-01 |
| Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression | [1]D V Havlir, [2]P B Gilbert, [3]K Bennett, [4]Ann C Collier, [5]M S Hirsch, [6]Pablo Tebas, [7]E M Adams, [8]L Joseph Wheat, [9]D Goodwin, [10]S Schnittman, [11]M K Holohan, [12]D D Richman, [13]ACTG 5025 Study Group [Full author list] | AIDS [curation] | DOI: 10.1097/00002030-200107270-00007
PubMed: 11504959 | hydroxyurea [curation] | 2001-07-01 |
| Timing of antiretroviral therapy. Use of Markov modeling and decision analysis to evaluate the long-term implications of therapy. | [1]Pablo Tebas, [2]Henry K, [3]Nease R, [4]Robert L. Murphy, [5]Phair J, [6]Powderly WG [Full author list] | AIDS [curation] | DOI: 10.1097/00002030-200103300-00008
PubMed: 11316996 | decision analysis [curation]; anti-retroviral agent [curation] | 2001-03-01 |
| Indinavir, nevirapine, stavudine, and lamivudine for human immunodeficiency virus-infected, amprenavir-experienced subjects: AIDS Clinical Trials Group protocol 373. | [1]R M Gulick, [2]L M Smeaton, [3]Richard T D'Aquila, [4]Joseph J Eron, [5]J S Currier, [6]J G Gerber, [7]E Acosta, [8]J P Sommadossi, [9]R Tung, [10]S Snyder, [11]D R Kuritzkes, [12]Robert L. Murphy, [13]AIDS Clinical Trials Group 373 Study Team, [13-Q42618377]Pablo Tebas [Full author list] | Journal of Infectious Diseases [curation] | DOI: 10.1086/318820
PubMed: 11181147 | nevirapine [curation]; lamivudine [curation]; stavudine [curation]; indinavir [curation] | 2001-01-30 |
| Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients | [1]X J Zhou, [2]D V Havlir, [3]D D Richman, [4]E P Acosta, [5]M Hirsch, [6]Ann C Collier, [7]Pablo Tebas, [8]J P Sommadossi, [9]AIDS Clinical Trials Study 343 Investigators [Full author list] | AIDS [curation] | DOI: 10.1097/00002030-200012220-00008
PubMed: 11153668 | zidovudine [curation]; pharmacokinetics [curation]; lamivudine [curation]; indinavir [curation] | 2000-12-01 |
| Response to 'Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy' by Drs Weil and Lenhard | [1]Pablo Tebas, [2]William Powderly, [2-Q61989166]William G Powderly, [3]Kevin Yarasheski [Full author list] | AIDS [curation] | DOI: 10.1097/00002030-200010200-00031
PubMed: 11089638 | | 2000-10-01 |
| Dynamics of HIV-1 viral load rebound among patients with previous suppression of viral replication. | [1]John Ioannidis, [2]Havlir DV, [3]Pablo Tebas, [4]Hirsch MS, [5]Ann C Collier, [6]Richman DD [Full author list] | AIDS [curation] | DOI: 10.1097/00002030-200007280-00003
PubMed: 10983634 | viral load [curation] | 2000-07-01 |
| A comparison of stavudine plus lamivudine versus zidovudine plus lamivudine in combination with indinavir in antiretroviral naive individuals with HIV infection: selection of thymidine analog regimen therapy (START I) | [1]K E Squires, [2]R Gulick, [3]Pablo Tebas, [4]J Santana, [5]V Mulanovich, [6]R Clark, [7]B Yangco, [8]S I Marlowe, [9]D Wright, [10]C Cohen, [11]Timothy Cooley, [12]J Mauney, [13]K Uffelman, [14]N Schoellkopf, [15]R Grosso, [16]M Stevens [Full author list] | AIDS [curation] | DOI: 10.1097/00002030-200007280-00015
PubMed: 10983646 | zidovudine [curation]; lamivudine [curation]; stavudine [curation]; indinavir [curation]; anti-retroviral agent [curation] | 2000-07-01 |
| Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy | [1]Pablo Tebas, [2]W G Powderly, [3]S Claxton, [4]D Marin, [5]W Tantisiriwat, [6]S L Teitelbaum, [7]Kevin Yarasheski [Full author list] | AIDS [curation] | DOI: 10.1097/00002030-200003100-00005
PubMed: 10770534 | anti-retroviral agent [curation] | 2000-03-01 |
| Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavir | [1]Pablo Tebas, [2]A K Patick, [3]E M Kane, [4]M K Klebert, [5]J H Simpson, [6]A Erice, [7]William G Powderly, [8]K Henry [Full author list] | AIDS [curation] | DOI: 10.1097/00002030-199902040-00002
PubMed: 10202820 | patient [curation]; ritonavir [curation]; saquinavir [curation]; nelfinavir [curation] | 1999-02-01 |
| Use of the polymerase chain reaction in the diagnosis of herpes simplex encephalitis: a decision analysis model | [1]Pablo Tebas, [2]Nease RF, [3]Storch GA [Full author list] | American Journal of Medicine [curation] | DOI: 10.1016/S0002-9343(98)00259-9
PubMed: 9809689 | encephalitis [curation]; decision analysis [curation] | 1998-10-01 |
| Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team | [1]D V Havlir, [2]Ian C. Marschner, [3]M S Hirsch, [4]Ann C Collier, [5]Pablo Tebas, [6]R L Bassett, [7]J P Ioannidis, [8]M K Holohan, [9]R Leavitt, [10]G Boone, [11]D D Richman [Full author list] | The New England Journal of Medicine [curation] | DOI: 10.1056/NEJM199810293391801
PubMed: 9791141 | | 1998-10-01 |
| Herpes simplex virus type 2 meningitis in the absence of genital lesions: improved recognition with use of the polymerase chain reaction | [1]Schlesinger Y, [2]Pablo Tebas, [3]Gaudreault-Keener M, [4]Buller RS, [5]Storch GA [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1093/CLINIDS/20.4.842
PubMed: 7795083 | meningitis [curation] | 1995-04-01 |
| Rapid development of resistance to clarithromycin following monotherapy for disseminated Mycobacterium chelonae infection in a heart transplant patient. | [1]Pablo Tebas, [2]Sultan F, [3]Wallace RJ Jr, [4]Fraser V [Full author list] | Clinical Infectious Diseases [curation] | DOI: 10.1093/CLINIDS/20.2.443
PubMed: 7742453 | clarithromycin [curation]; patient [curation]; Mycobacterium chelonae [curation] | 1995-02-01 |
| Association between porphyria cutanea tarda and human immunodeficiency virus infection | [1]Pablo Tebas, [2]Arzauga JA, [3]Roman F, [4]Maestu RP, [5]de Letona JM [Full author list] | JAMA Internal Medicine [curation] | DOI: 10.1001/ARCHINTE.152.8.1726A
PubMed: 1497409 | porphyria cutanea tarda [curation] | 1992-08-01 |
| Association Between Porphyria Cutanea Tarda and Human Immunodeficiency Virus Infection | [1]Pablo Tebas [Full author list] | JAMA Internal Medicine [curation] | DOI: 10.1001/ARCHINTE.1992.00400200148034
| porphyria cutanea tarda [curation] | 1992-08-01 |
| Non-tropical pyomyositis caused by Salmonella enterica enterica in an immunocompetent patient. | [1]Pablo Tebas, [2]F Bonilla, [3]J Ruiz, [4]B Diéguez, [5]P España [Full author list] | European Journal of Clinical Microbiology & Infectious Diseases [curation] | DOI: 10.1007/BF01960817
PubMed: 1526245 | pyomyositis [curation]; Salmonella enterica [curation] | 1992-06-01 |